Unified clinical trial software
Unified clinical trial software for animal health trials
oomnia connects clinical workflows for animal health studies, enabling teams to manage diverse species, data sources, and study designs with greater efficiency, data quality, and oversight
INDUSTRY CONTEXT
Why animal health trials are hard to run
Animal health trials bring unique complexity compared to human studies, driven by multiple species, variable environments, and diverse endpoints across companion animals, livestock, and specialty populations. These factors make study execution less standardized and more difficult to manage consistently across sites.
Key execution challenges include:
Multi‑species variability affecting dosing, endpoints, and study design
Inconsistent data collection across clinics, farms, and field settings
Limited standardization of outcome measures across animal types
Fragmented data from labs, imaging, and field observations
Difficulty tracking longitudinal health outcomes in real‑world environments
Operational complexity across distributed veterinary sites and regions
UNIFIED PLATFORM
Why unified clinical trial software matters for animal health trials
Animal health studies often rely on multiple disconnected tools to handle clinical data, operational workflows, lab results, and field data collection. This fragmented setup increases manual work, introduces inconsistencies, and slows down insight generation.
A unified clinical trial platform, built as a Clinical Research Information System (CRIS), connects all study components in one environment.
This enables consistent data flow, improved quality, and real‑time oversight across animal health research.
| Area | Modular eClinical system | Unified clinical trial software (oomnia) |
|---|---|---|
| Data types | Clinical, lab, and field data stored separately | All animal health data unified in one system |
| Data consistency | Variability across species, sites, and data sources | Standardized data across studies |
| Reconciliation | Manual alignment of clinical and field data | Reduced reconciliation through shared data model |
| Monitoring | Delayed visibility into health outcomes | Real‑time tracking across study duration |
| Execution | Disconnected workflows across sites and partners | Unified workflows across all stakeholders |
| Data quality | Higher risk of inconsistencies and gaps | Structured capture with built‑in validation |
| Oversight | Limited cross‑study visibility | Centralized oversight across programs |
| Scalability | Difficult to scale multi‑region studies | Scalable across species and geographies |
CRIS ARCHITECTURE
One unified clinical trial platform for animal health trials
oomnia brings together core trial operations into a single Clinical Research Information System (CRIS), supporting the complexity of animal health studies across species and environments
Designed to handle multi‑species data and diverse endpoint types
Shared data model aligns clinical, operational, and observational data
Flexible configuration allows protocol adjustments without system rebuilds
Replaces disconnected tools with one coordinated workflow
ECOSYSTEM INTEGRATION
How oomnia fits in the animal health sponsor ecosystem
oomnia acts as a centralized operational and data hub for animal health trials, connecting study stakeholders and systems across veterinary research environments
It integrates:
KEY CAPABILITIES
Key capabilities for animal health trials
Study design and protocol flexibility
- Supports diverse study designs across species, including controlled trials, field studies, and longitudinal monitoring
- Adapts to protocol changes such as dosing adjustments, visit schedules, or species‑specific endpoints
- Maintains consistency across sites and regions during mid‑study updates
Data capture and quality
- Enables real‑time capture of clinical observations, lab data, imaging, and field inputs
- Unifies EDC, CTMS, RTSM, ePRO/eCOA, eTMF, eSource, and eConsent within one system
- Reduces manual reconciliation across veterinary clinics, labs, and field environments
Animal monitoring
- Supports both site‑based and remote data collection, including farm and in‑home monitoring
- Captures observational data, caregiver inputs, and device‑generated information
- Improves data completeness through structured workflows and reminders
Oversight and analytics
- Provides centralized dashboards across species, sites, and study phases
- Supports safety monitoring, interim analysis, and operational decision‑making
- Delivers structured datasets for reporting and regulatory submission
Laboratory and biomarker integration
- Integrates diagnostic lab data, microbiology results, and biomarker testing
- Links laboratory findings with clinical outcomes and treatment response
- Provides a consolidated view of animal health data across studies
Designed for multi‑species research and real‑world study environments
Unified architecture eliminates fragmented systems and integrations
Flexible configuration supports evolving protocols and endpoints
Simplifies workflows across veterinary sites, CROs, and partners
VALUE PROPOSITION
Why sponsors choose oomnia for animal health trials
Client Testimonials
Collaboration built on trust and innovation
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions to ensure the study's goals and objectives were clearly defined and the operating structure matched with the study's intent. Their system is not a one-size-fits-all and they adapt to the needs of the sponsor, sites, physicians, and the study requirements into a system that merges health information/data and can then become not only informative but actionable.
James Kuras
Vice President of Clinical Affairs and Operations at Centinel Spine
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their speed of addressing customer needs sets in my personal experience industry benchmark whilst keeping these data solutions lean and affordable. Besides the great proprietary systems they use, their integrated team approach with personal responsibility and honest commitment to targeting outcomes differentiates the Wemedoo team from other providers. Wemedoo only made Oxular's key initial trial, a device-drug trial possible, as based on some pre-work, the Wemedoo team could substantially adapt and update the first EDC ideas for a trial under a US FDA IND. The Wemedoo team worked extremely focused on familiarizing US trial sites and clinical CROs with the use of their system, which turned out to be a key success factor of the respective trial. The highly professional and up-to-date capabilities in data sciences were mirrored by customer-centricity and super fast timelines of integrating mandatory adaptations to the data systems.
Friedrich Asmus
Former Chief Medical Officer at OXULAR
All jobs, both large and small, are performed with the same dedication to quality, detail, innovative thinking, and rigor. It is always a pleasure to work with the Wemedoo team.
Georg Mathis, PhD
CEO at Appletree CI Group AG
Wemedoo embodies all the traits desired in a partner in the clinical trial industry – expertise, innovation, reliability, compliance, and attention to detail.
Martina Diminic Smetisko, DMD
Managing Director at Marti Farm Ltd
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am looking forward to our next project together.
Volodymyr Stus, MD
Biopharmaceutics and Clinical Research Department Manager at Polpharma SA
Complex adaptive trials demand speed, precision, and system stability. With oomnia, Wemedoo's unified clinical trial software maintained continuous drug supply oversight, real-time data capture above 99%, and zero Randomization and Trial Supply Management (RTSM) dispensing errors throughout the study. The study reached database lock within 3 days after Last Patient Last Visit (LPLV), a direct result of integrated EDC–RTSM execution and proactive technical support. Wemedoo's technology and team responsiveness played a key role in meeting aggressive milestones.
Dhiraj Patel, Dr.
Director at Velocious Clinical Research
REGULATORY READINESS
Regulatory and data infrastructure readiness
oomnia provides a compliance‑ready environment aligned with the regulatory and data requirements of animal health research
21 CFR Part 11–compliant records
21 CFR Part 11–compliant electronic records with full audit trails for inspection-ready documentation
ICH E6(R3)–aligned oversight
ICH E6(R3)‑aligned risk‑based oversight applied where applicable to animal health study contexts
CDISC-aligned data structures
CDISC‑aligned data structures where applicable for standardized and submission-ready outputs
Global regulatory submissions
Support for global regulatory submissions across regions and animal health research programs
Get Started
Run animal health trials with less complexity
Connect data and workflows across sites, labs, and field environments to simplify execution and improve study oversight
Talk to our team